- Home
- PLSE vs ITGR Comparison
PLSE vs ITGR Comparison
Compare PLSE & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | ITGR |
|---|---|---|
| Founded | 2014 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.3B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PLSE | ITGR |
|---|---|---|
| Price | $53.63 | $126.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 9 |
| Target Price | $62.33 | ★ $127.00 |
| AVG Volume (30 Days) | 354.5K | ★ 775.9K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.60 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $480.71 | N/A |
| Revenue Next Year | $177.98 | $5.97 |
| P/E Ratio | ★ N/A | $79.15 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $12.56 | $66.51 |
| 52 Week High | $58.90 | $126.83 |
Technical Indicators
Market Signals| Indicator | PLSE | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 59.03 |
| Support Level | $49.01 | $126.50 |
| Resistance Level | $56.54 | $126.80 |
| Average True Range (ATR) | 3.59 | 0.17 |
| MACD | 0.12 | -0.08 |
| Stochastic Oscillator | 43.41 | 31.34 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.